Our Pricing

Published on: June 03, 2026

When you buy Wegovy online prescription UK services through Cured Pharmacy, you access genuine UK-licensed semaglutide injections from £79.00, supported by a free clinical consultation with our registered prescribers. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every patient receives safe, evidence-based weight management treatment with complete transparency on pricing before you begin your assessment.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a naturally occurring hormone in your body. This medication works by slowing gastric emptying, reducing appetite signals to the brain, and improving blood sugar regulation — three mechanisms that work together to support sustainable weight reduction [1].

In the landmark STEP 1 clinical trial, adults using Wegovy alongside lifestyle interventions achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results demonstrated that semaglutide 2.4mg once weekly produces clinically meaningful weight loss when combined with a reduced-calorie diet and increased physical activity.

The medication is licensed by the MHRA for weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension or type 2 diabetes [2]. Your UK prescriber will assess your individual circumstances during the online consultation to determine if Wegovy is clinically appropriate for you.

Wegovy Dosing Schedule and What to Expect

Each Wegovy pen is pre-filled and designed for once-weekly subcutaneous injection into your abdomen, thigh, or upper arm. The injection process takes less than a minute, and our clinical team provides comprehensive instructions with your first prescription to ensure you feel confident administering the treatment at home.

Weight loss typically becomes noticeable within the first 4-8 weeks, with the most significant reductions occurring between weeks 20 and 60 of treatment [1]. Your UK prescriber will schedule regular follow-up consultations to monitor your progress, adjust your treatment plan if needed, and ensure you're achieving safe, sustainable results.

The Gradual Dose Escalation Protocol

Wegovy follows a carefully structured dose escalation over 16-20 weeks to minimise gastrointestinal side effects whilst your body adjusts to the medication. You'll start with 0.25mg once weekly for four weeks, then progress through 0.5mg, 1mg, and 1.7mg doses before reaching the maintenance dose of 2.4mg weekly [2].

This gradual approach, validated in clinical trials, significantly reduces the likelihood of nausea and vomiting — the most commonly reported side effects during initiation. Most patients find these symptoms mild and transient, typically resolving within the first few weeks at each dose level.

Buy Wegovy Online Prescription UK: The Cured Pharmacy Process

Once your prescription is approved, we dispense genuine UK-licensed Wegovy from our GPhC-registered pharmacy (9012511) and arrange discreet delivery to your preferred address. All packaging is unmarked, and you can track your order from dispatch to delivery.

We guarantee the lowest prices in the UK for Wegovy, and our transparent pricing model means you'll never pay more than the amount shown during your consultation. If you have questions at any stage, our pharmacy team is available on (+44) 116 4646009 during business hours.

Your Free Online Consultation

Our streamlined consultation takes under three minutes to complete and covers your medical history, current medications, weight management goals, and any contraindications. A UK-registered prescriber reviews every assessment individually — this isn't an automated approval system, but genuine clinical oversight by qualified healthcare professionals.

You'll see transparent pricing before you begin the consultation, with no hidden fees or surprise charges at checkout. If Wegovy isn't suitable for your circumstances, your prescriber may recommend alternative treatments or suggest discussing options with your GP.

Wegovy Side Effects and Safety Considerations

The most frequently reported side effects in clinical trials were gastrointestinal: nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) [1]. These effects are typically mild to moderate, occur predominantly during dose escalation, and diminish as treatment continues.

Serious but rare risks include pancreatitis, gallbladder problems, and potential thyroid C-cell tumours (observed in rodent studies but not conclusively demonstrated in humans) [2]. Wegovy is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Your prescriber will assess your full medical history to identify any contraindications before approving treatment. You should contact a healthcare professional immediately if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction whilst using Wegovy.

Wegovy vs Other Weight Loss Treatments Available in the UK

Orlistat represents a non-injectable alternative that works by blocking fat absorption in the digestive system, though clinical trials show more modest weight reductions compared to GLP-1 medications [3]. It may suit patients who prefer oral medication or have contraindications to injectable treatments.

During your consultation, our UK prescribers can discuss the full range of licensed weight management options and recommend the treatment most likely to deliver safe, effective results based on your individual clinical profile.

Comparing GLP-1 Receptor Agonists

Several prescription weight loss medications are now licensed in the UK, each with distinct mechanisms and evidence bases. Semaglutide-based treatments like Wegovy activate a single GLP-1 pathway, whilst newer dual-agonist medications target both GLP-1 and GIP receptors for potentially enhanced efficacy.

Your choice of treatment depends on multiple factors: your weight loss goals, tolerance for injection frequency, budget considerations, and how your body responds to the medication. Some patients achieve excellent results with daily injectable options, whilst others prefer the convenience of once-weekly administration.

Maximising Your Results with Wegovy

Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activity — not as a standalone solution [2]. Clinical trial participants who achieved the best outcomes combined the medication with structured lifestyle interventions, including nutritional counselling and regular exercise programmes.

NICE guidance recommends aiming for a 5-10% body weight reduction as an initial goal, as this level of weight loss produces meaningful improvements in cardiovascular risk factors, blood pressure, and glycaemic control in patients with type 2 diabetes [4]. Wegovy can help you achieve and maintain these clinically significant reductions when used as part of a comprehensive weight management strategy.

Your prescriber may recommend regular monitoring of your weight, BMI, and any weight-related comorbidities throughout treatment. If you haven't achieved at least 5% weight loss after 12-16 weeks at the maintenance dose, your prescriber will reassess whether continuing Wegovy remains appropriate for you [2].

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Torgerson, J. S., et al. (2004). XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Obesity: Identification, Assessment and Management (CG189). NICE Clinical Guideline. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.